Clinical Trial

Pancreatic Adenocarcinoma Gene Environment Risk Study

Study acronym: PAGER
Recruiting
View on ClinicalTrials.gov →
Summary
After informed consent, participants will be asked to complete a medical/family history questionnaire and provide a blood sample. Some participants may also be asked to provide a urine sample. Individuals undergoing procedures that require collection of biological samples for clinical purposes may have these samples saved for research purposes. Participants will also be asked for their permission for study investigators to access medical records and/or recontact them for updates to their medical and family histories. Data and biospecimens will be stored for potential future research projects.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2009-06-02; most recent amendment 2025-11-18.
Trial Details
NCT Number NCT00912717
Lead Sponsor University of Pittsburgh
Conditions Pancreatic Cancer
Enrollment 10,000 participants
Start Date 2004-01
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-19